Raj Parekh
InvestorGeneral Partner at Advent Life Sciences · Board director at Arrakis Therapeutics · Board director at Macrolide Pharmaceuticals · Board director at Artax Biopharma
Los Altos, California
Writes $25K – $5M checks · typically $1M
About
Raj Parekh joined Advent in 2005, bringing over 20 years of experience across biomedical research, entrepreneurship, and investing. He holds an MA and DPhil from Oxford University, worked in molecular medicine academia, and co-founded Oxford GlycoSciences (which went public on the LSE and NASDAQ and was later sold to UCB-Celltech). He has also served as Chairman of Galapagos nv, on the Supervisory Board of the Novartis Venture Fund, and as a founding Director of Celldex Therapeutics. At Advent, he focuses on founding and supporting portfolio companies developing new medicines.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Arrakis Therapeutics
Intro paths
In turn, Raj can intro founders to Arrakis Therapeutics's investors below.
Arrakis Therapeutics's investors · 8
Co-founders at Arrakis Therapeutics
Board director at Macrolide Pharmaceuticals
Intro paths
In turn, Raj can intro founders to Macrolide Pharmaceuticals's investors below.
Macrolide Pharmaceuticals's investors · 2
Board director at Artax Biopharma
Intro paths
In turn, Raj can intro founders to Artax Biopharma's investors below.
Artax Biopharma's investors · 3
Co-founders at Artax Biopharma
Experience
- CellworksExecutive Advisorcurrent2026 — present
- Silicon CatalystStrategic Advisorcurrent2024 — presentUnited States
- DYCM Power, LLCExecutive Advisorcurrent2024 — presentUnited States
- e6dataExecutive Advisorcurrent2023 — presentUnited States
- iCoin TechnologyBoard Advisorcurrent2021 — presentUnited States
- LavorroBusiness Advisorcurrent2021 — presentUnited States
- The Modern Data CompanyStrategic Advisor2023 — 2026United States
- Kencor HealthExecutive Advisor2020 — 2026United States
- Redwood VenturesChairman, Co-Founder and Managing Director1998 — 2022
- PranalyticaExecutive Advisor2005 — 2022United States
- PranalyticaEx-Director2018
- TiE angelsSteering Committee2010 — 2020California
- HomeUnion (sold to Myand)Member of the Board2017 — 2018Orange County, California, United States
- ColorTokens, Inc.Founder, Ex-CEO and Board of Directors2014 — 2018Bay Area, California
- Glassbeam, IncEx-Board of Directors2010 — 2016
- CloudVolumes Inc. (Sold to VMware)CEO, President and Board of Directors2011 — 2014Silicon Valley
- VMwareVMware Partner2013 — 2014
- SAPExecutive Advisor2012
- Virident Systems (sold to Western Digital)Co-Founder, Ex CEO and Chairman2006 — 2012
- Sun Microsystems IncCTO, GM and Vice President Engg.1992 — 1998
- Silicon Graphics IncVice President and General Manager1982 — 1992
Skills & more
+12 more
Account ManagementEmployee EngagementP&L ManagementInternational Business DevelopmentGlobal BusinessConsultingBusinessCloud ComputingCritical ThinkingCommunicationDelegationEnglishFrom Raj's professional profile.
Deals · 3
Artax BiopharmaBoard seat
via Advent Life Sciences · filed May 2026 · $19M raise
Macrolide PharmaceuticalsBoard seat
via Advent Life Sciences · filed Mar 2018 · $20M raise
Arrakis TherapeuticsBoard seat
via Advent Life Sciences · filed Mar 2017 · $41.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
ALETAAmphistaArtaxAura BiosciencesAvila TherapeuticsCn CreativeEUSA PharmaLevicept
Sources: the firm's website · SEC Form D filings.
Colleagues at Advent Life Sciences
Frequently asked questions
- Who is Raj Parekh?
- Raj Parekh joined Advent in 2005, bringing over 20 years of experience across biomedical research, entrepreneurship, and investing. He holds an MA and DPhil from Oxford University, worked in molecular medicine academia, and co-founded Oxford GlycoSciences (which went public on the LSE and NASDAQ and was later sold to UCB-Celltech). He has also served as Chairman of Galapagos nv, on the Supervisory Board of the Novartis Venture Fund, and as a founding Director of Celldex Therapeutics. At Advent, he focuses on founding and supporting portfolio companies developing new medicines.
- Where does Raj Parekh work?
- Raj Parekh is General Partner at Advent Life Sciences and Board director at Arrakis Therapeutics and Board director at Macrolide Pharmaceuticals and Board director at Artax Biopharma.
- What does Raj Parekh invest in?
- Raj Parekh invests in Biotech.
- What check size does Raj Parekh write?
- Raj Parekh typically writes checks of $25K – $5M.
- What boards does Raj Parekh sit on?
- Raj Parekh holds tracked board seats at ALETA, Amphista, Arrakis Therapeutics, Arrakis Therapeutics, Artax, Artax Biopharma, Aura Biosciences, Avila Therapeutics, Cn Creative, EUSA Pharma.
- Where did Raj Parekh go to school?
- Raj Parekh studied at The Polytechnic Institute of New York University (MSEE, Electrical engineering); Lalbhai Dalpatbhai (L.D.) College of Engineering, Ahmedabad (BSEE, Electrical Engineering); R. K. Gharshala, Bhavnagar, India (SSC, Technical).
Same school
Also attended The Polytechnic Institute of New York University1
Shared employers
Also worked at The Modern Data Company2
Also worked at Glassbeam, Inc1
Also worked at SAP161
.png)
+ 155 more
Also worked at Sun Microsystems Inc136
+ 130 more